[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337795-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337795-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-modules-and-key-genes-associated-with-breast-cancer-subtypes-through-network-analysis","Identification of modules and key genes associated with breast cancer subtypes through network analysis","","Breast cancer remains the most common malignancy in women, with persistent intratumor and intertumoral heterogeneity that makes biomarker discovery essential. This study applies Weighted Gene Co-expression Network Analysis to 28,143 genes across 49 breast cancer cell lines to characterize Basal A, Basal B, Luminal A, Luminal B, and HER2-amplified subtypes. Sixty-five modules are identified, and five show high subtype correlation. Hub genes include IFIT3, ETS1, a cancer-expressed lncRNA, and TMEM86A, linking overexpressed genes to apoptosis regulation, transcriptional control, angiogenesis, signaling, and cellular survival, supporting subtype-specific biomarkers or therapeutic targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-modules-and-key-genes-associated-with-breast-cancer-subtypes-through-network-analysis/337795/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-modules-and-key-genes-associated-with-breast-cancer-subtypes-through-network-analysis/337795.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What method and dataset were used to analyze breast cancer subtypes?","Question",{"text":63,"@type":64},"The study uses Weighted Gene Co-expression Network Analysis on 28,143 genes expressed in 49 breast cancer cell lines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many gene modules were identified, and what was notable about five of them?",{"text":68,"@type":64},"Sixty-five modules were identified, and five were characterized as having a high correlation with breast cancer subtypes.",{"name":70,"@type":61,"acceptedAnswer":71},"Which hub genes were highlighted as key candidates for subtype-related biology?",{"text":72,"@type":64},"The paper highlights hub genes including IFIT3, ETS1, an lncRNA identified in cancers (ENSG00000259723), AL033519.3, and TMEM86A, among others.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337795,1790842104,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of modules and key genes associated with breast cancer subtypes through network analysis  \nMaría Daniela Mares‑Quiñones1, Edgardo Galán‑Vásquez2, Ernesto Pérez‑Rueda 3,  \nD. Guillermo Pérez‑Ishiwara1, María Olivia Medel‑Flores1 & María  \ndel Consuelo Gómez‑García1*  \nBreast cancer is the most common malignancy in women around the world. Intratumor and intertumoral heterogeneity persist in mammary tumors. Therefore, the identification of biomarkers is essential for the treatment of this malignancy. This study analyzed 28,143 genes expressed in 49 breast cancer cell lines using a Weighted Gene Co‑expression Network Analysis to determine specific target proteins for Basal A, Basal B, LuminalA, Luminal B, and HER2 ampl breast cancer subtypes. Sixty‑five modules were identified, of which five were characterized as having a high correlation with breast cancer subtypes. Genes overexpressed in the tumor were found to participate in the following mechanisms: regulation ofthe apoptotic process, transcriptional regulation, angiogenesis, signaling, and cellular survival. In particular, we identified the following genes, considered as hubs: IFIT3, an inhibitor of viral and cellular processes; ETS1, a transcription factor involved in cell death and tumorigenesis; ENSG00000259723 lncRNA, expressed in cancers; AL033519.3, a hypothetical gene; and TMEM86A, important for regulating keratinocyte membrane properties, considered as a key in Basal A, Basal B, LuminalA, Luminal B, and HER2 ampl breast cancer subtypes, respectively. The modules and genes identified in this work can be used to identify possible biomarkers or therapeutic targets in different breast cancer subtypes.  \nBreast cancer (BC) is the most common malignancy in women and the second leading cause of cancer-related deaths in developed and industrialized countries. In 2020, there were 2.3 million new cases and 685,000 deaths worldwide1. BC is a process characterized by uncontrolled cell proliferation in the cells of the mammary glands, in which mutations are progressively acquired, generating genomic instability2.  \nThe two most common types of BC by origin are ductal and lobular3. However, great morphological and biological heterogeneity generates Intrinsic Subtypes of Breast Cancer (ISBC) such as Luminal A and Luminal B, Basal-like, low in claudin, over-expressed with HER2, triple-negative, and normal type4. Intrinsic surrogate subtypes are also classified into triple-negative, over-expressed with HER2, Luminal B as HER2+, Luminal Bas HER2−, and Luminal A4. Intrinsic surrogate subtypes are also classified into triple-negative, over-expressed with HER2, Luminal B as HER2+, Luminal B as HER2−, and Luminal A. This heterogeneity, in turn, generates differences in clinical behavior, pathological characteristics, and treatment responses, among others5–7.  \nAn essential issue for treatment is the selection of the correct therapeutic modality, which largely depends on the Subtype of Breast Cancer (SBC)8. This is crucial because when BC is diagnosed early and managed with a multidisciplinary approach, it becomes a potentially curable disease9. To date, the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) are utilized as biomarkers to streamline clinical decision-making, providing prognostic information, and predict responses to targeted therapies10. Currently, BRCA1, BRCA2, and TP53 genes; STAT3, ESR1, and MUC-1 proteins; miRNAs (26b-5p,  \n1Laboratorio de Biomedicina Molecular, Programa de Doctorado en Biotecnología, Escuela Nacional de Medicinay Homeopatía, Instituto Politécnico Nacional, Ciudad de México, Mexico. 2Departamento de Ingeniería de Sistemas Computacionales y Automatización, Instituto de Investigaciones en Matemáticas Aplicadas y en Sistemas, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de México","cbCaihjmzouJWruK","https://ap.wps.com/l/cbCaihjmzouJWruK","pdf",7820736,18,"English","# Introduction\n## Breast cancer heterogeneity and intrinsic subtypes\n## Biomarkers and therapeutic modality selection\n## Previous bioinformatics targets and need for subtype-specific biomarkers","[{\"question\":\"What method and dataset were used to analyze breast cancer subtypes?\",\"answer\":\"The study uses Weighted Gene Co-expression Network Analysis on 28,143 genes expressed in 49 breast cancer cell lines.\"},{\"question\":\"How many gene modules were identified, and what was notable about five of them?\",\"answer\":\"Sixty-five modules were identified, and five were characterized as having a high correlation with breast cancer subtypes.\"},{\"question\":\"Which hub genes were highlighted as key candidates for subtype-related biology?\",\"answer\":\"The paper highlights hub genes including IFIT3, ETS1, an lncRNA identified in cancers (ENSG00000259723), AL033519.3, and TMEM86A, among others.\"}]","Identification of modules and key genes associated with breast cancer subtypes through network analysis | PDF",1790020659,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fde9ff2136f276723724247a7427bb6.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96355698f09d97e205c208247498ddb0.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/365bd0f65b9ec18465a5339fb60a7a5b.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a535d1d4670882b4fe7d7231f6475cb.webp",980,1287]